Sewon Cellontech Obtains Patent Related to Cartilage Tissue Treatment

by Oh Jooyean

Published 30 Jan.2020 09:18(KST)

[Asia Economy Reporter Oh Ju-yeon] Sewon Cellontech announced on the 30th that it has completed patent registration in Brazil for the 'Composition for Cartilage Tissue Repair, Manufacturing Method, and Its Usage Method.'

Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

Brilliant Korean Technology Flows Overseas... Subsidies Granted, but "No Product Launch Allowed"
"No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Singer Kim Minjong Responds to MC Mong's Gambling Allegations: "Clearly False... Legal Action to Follow"
Instead of a National Assembly Profile, Now a 'Carpenter'... Ryu Hojung Says "I Couldn't Do a Body Profile Shoot Twice"

The company stated, "By applying biocollagen, a biocompatible material, as a non-surgical treatment, we aim to help patients reduce costs and quickly return to daily life," adding, "We seek to improve quality of life through the restoration of joint function."

한글 기사 보기

This content was produced with the assistance of AI translation services.